DuPont de Nemours, Inc. Earnings Recaps
Q1 2026
May 7, 2026
Shares popped 10.3% as DuPont delivered better-than-expected organic sales growth and margin expansion, prompting a full-year guidance raise and an accelerated share repurchase announcement.
Key takeaways
- Reported 2% organic sales growth and 130 basis points of pro forma margin expansion in Q1.
- Achieved double-digit adjusted EPS growth supported by disciplined commercial and operational execution.
- Raised full-year 2026 financial guidance, citing strong first-quarter performance and price increases related to the Middle East conflict.
- Announced a $275 million accelerated share repurchase under the existing program, signaling confidence in cash flow and capital allocation.
- Continued operational improvements with better asset reliability, equipment effectiveness, and productivity initiatives underpinned by digital and AI tools.
Q3 2025
Nov 6, 2025
DuPont reported robust third-quarter results, with net sales increasing by 6% year-over-year and operating EBITDA growing to $840 million, leading to an upward revision of full-year earnings guidance.
Key takeaways
- Net sales reached $3.1 billion, driven by strong organic growth across all business segments, particularly in healthcare and electronics.
- Operating EBITDA margin improved to 27.3%, reflecting effective operational management and cost controls.
- The Board authorized a $2 billion share repurchase program and declared an initial quarterly dividend of $0.20 per share, emphasizing a commitment to shareholder value.
- The successful separation of Qnity positions DuPont to capitalize on semiconductor market opportunities and strengthen its pure-play technology offerings.
- Continued emphasis on innovation was highlighted with the launch of new technologies in personal protective equipment, reinforcing DuPont's market leadership.